In a statement, Bristol-Myers Squibb Co and Eisai Co said, they had entered into an agreement to jointly develop and market an experimental cancer drug worth up to $3.10 billion. Bristol-Myers would pay $650 million, including for research and development… Read More ›
On Thursday, in a statement Netherlands Foreign Investment Agency stated, there has been a flow of businesses moving into the Netherlands because of Brexit; this is despite direct foreign investment dropping by a quarter because of the coronavirus-induced COVID-19 pandemic…. Read More ›
According to a Republican congressional aide briefed on the matter at hand, the United States plans on imposing fresh sanctions on Iran’s financial industry. The development comes ahead of a key U.S. election. The move is likely to shut out… Read More ›
On Monday, in a statement Israel’s Intelligence Minister Eli Cohen stated, the annual trade between Israel and the United Arab Emirates is likely to touch $4 billion. The development comes in the wake of an announcement by both countries that… Read More ›
According to a report from the Wall Street Journal, Swiss drugmaker Novartis AG is close to clinching an agreement to acquire U.S. biotechnology firm The Medicines Co for around $7 billion. In the potential deal, Novartis has agreed to pay… Read More ›
The deal sees Britain’s AstraZeneca Plc led by Pascal Soriot sharing development and commercialization costs for the drug worldwide. For AstraZeneca the deal makes sense as it will replenish its pipeline as its cancer drug sales grow. In a significant… Read More ›
The acquisition will add AveXis top drug to its repertoire of drugs, which has a significant market in the U.S. for spinal muscular atrophy. On Monday, Switzerland-based healthcare giant Novartis announced its $8.7 billion deal to acquire AveXis; Novartis will… Read More ›
Spectranetics specializes in cleaning up clogged arteries and veins. Dutch medical equipment manufacturer, Philips, has disclosed it will be acquiring U.S.-based Spectranetics Corp for $2.16 billion (1.9 billion euros), including debt. Spectranetics uses innovative techniques including, tiny drug-covered balloons and… Read More ›
The company has added three new directors to its board, thus extending it to 14 directors. NY-based activist investor, JANA partners has boosted its stake in the company, although sources say it is less than 1%. In a move that… Read More ›
Mallinckrodt Pharmaceuticals was caught raising prices of medicines for infants of less than a year old to skyrocketing prices. Mallinckrodt Pharmaceuticals, a drug manufacturer, has settled a lawsuit for $100 million with the US Federal Trade Commission (FTC) for having… Read More ›
manageria.biz 